the aid library

LIST OPTIONS

Filter

2328

Clinical management of diphtheria: guideline

World Health Organization WHO (2024) C_WHO

WHO has published the first-ever guidance on the clinical management of diphtheria. The only previously available guidance was an operational protocol. The new guidance followed the rigorous process for developing guidance at WHO. It addresses the use of Diphtheria Antitoxin (DAT) in the treatmen... more

Download (213)

View PDF (286)

Protocol for Enhanced Isolate-Level Antimicrobial Resistance Surveillance in the Americas. Primary Phase: Bloodstream Infections

Pan American Health Organisation PAHO (2021) C_WHO

Antimicrobial resistance (AMR) surveillance plays an important role in the early detection of resistant strains of public health importance and prompt response to outbreaks in hospitals and the community. Surveillance findings are needed to inform medical practice, antibiotic stewardship, and policy... more

Download (254)

View PDF (232)

Antimicrobial Resistance Background Document

National Department of Health South Africa (2019) C1

Antimicrobial resistance (AMR) is a multifaceted, international public health problem, which poses a direct threat to the safety of the population of South Africa. A national response is required to complement the development of a global plan, as articulated in the WHO’s draft resolution EB134/37 ... more

External Link

Antimicrobial stewardship programmes in health-care facilities in low- and middle-income countries: a WHO practical toolkit. Online Course

Open WHO; World Health Organization WHO (2022) C_WHO

The toolkit provides guidance on where to get started, including the structures and resources that should be put in place at the national and health-care facility level, through a stepwise approach in low-resource settings. As the ultimate goal of an AMS programme is sustainable behaviour change in ... more

Download (343)

View PDF (319)

Antimicrobial Resistance (AMR)

Deininger, K. The MEDBOX Team (2023) CC

Issue Brief 31: Antimicrobial resistance (AMR) can occur when viruses, bacteria, parasites and fungi change over time. There is no longer a response to medicines, and the infection treatment gets really difficult which increases the risk of a disesase spread, which can lead to severe health problems... more

External Link

Meningitis Outbreak Response in Sub-Saharan Africa

Christina Brandes-Barbier, Véronique Millot, Tomas Allen et al World Health Organization WHO (2014) C_WHO

WHO Guideline. Since 2010, countries in the meningitis belt have started to introduce a new serogroup A meningococcal conjugate vaccine conferring individual protection and herd immunity. Following the successful roll-out of this vaccine, epidemics due to Neisseria meningitidis serogroup A (NmA) are... more

Download (106)

View PDF (165)

First meeting of the network on Buruli ulcer PCR laboratories in the WHO African Region Centre Pasteur du Cameroon, Yaoundé, 21–24 October 2019

World Health Organization WHO (2020) CC

Research to develop point-of-care tests is in progress. Treatment of Buruli ulcer comprises 8 weeks of combined antibiotics (rifampicin and clarithromycin). Complementary therapies such as wound care, skin graft and prevention of disability are needed in some cases to ensure full recovery. The targ... more

Download (143)

View PDF (169)

Cotonou declaration on buruli ulcer
recommended

World Health Organization WHO (2009) CC

Cotonou Declaration oBuruli Ulcer Cotonou, Benin, 30 March 2009 Neglected tropical diseases kill, weaken or incapacitate millions of people every year, causing permanent physical suffering, social stigmatization and reduced productive capacity. Buruli ulcer, one such disease, causes immense suffer... more

Download (731)

View PDF (1106)

National Antibiotic Treatment Guideline (Nepal)

Government of Nepal; Ministry of Health and Population (2014) C1

Cotonou declaration on buruli ulcer recommended

Cotonou declaration on buruli ulcer
recommended